James Patrick Tursi - 15 Jul 2022 Form 4 Insider Report for Endo International plc

Reporting relationship: Executive VP, Global R&D
Issuer ticker: N/A
Reported as of: 15 Jul 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Aug 2022, 06:31:28 UTC
Prior SEC filing: 10 Jun 2022
Next SEC filing: 02 Nov 2023
Source filing: View source filing
Reporting owner signature: /s/ Matthew J. Maletta, by power of attorney

Key filing fact

James Patrick Tursi filed Form 4 for Endo International plc on 17 Aug 2022.

Key facts

This page summarizes James Patrick Tursi's Form 4 filing for Endo International plc.
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Aug 2022, 06:31.

Change

Previous filing in this sequence was filed on 10 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ENDPQ transaction

2015 Stock Incentive Plan Restricted Stock Units (RSU)

Disposed to Issuer

Transaction value
Shares: -280,373
Change %: -100%
Price
Shares after: 0
Date: 15 Jul 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On July 15, 2022, Dr. Tursi received cash totaling $900,000 in respect of his outstanding RSUs. Upon receipt of this cash payment, the corresponding RSUs were cancelled.